Rare disease diagnosis in China is experiencing a transformative period in 2026, with whole exome sequencing and whole genome sequencing technologies enabling genetic diagnosis for thousands of previously undiagnosed patients with rare Mendelian conditions whose families had spent years or sometimes decades seeking an explanation for symptoms that defied conventional clinical investigation. The...